Added to YB: 2023-08-12
Pitch date: 2023-08-12
9776.T [bullish]
Sapporo Clinical Laboratory Inc.
+94.17%
current return
Author Info
Company Info
Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company engages in contract and agency services for various clinical testing and public health testing, as well as food hygiene testing; sales and maintenance of software, such as clinical testing systems; management of dispensing pharmacies; and pharmaceutical wholesale.
Market Cap
JPY 6.1B
Pitch Price
JPY 1.0K
Price Target
N/A
Dividend
N/A
EV/EBITDA
3.60
P/E
15.77
EV/Sales
0.23
Sector
Consumer Staples Distribution and Retail
Category
value
Sapporo Clinical Laboratory Inc (TYO 9776) - A Cheap Yet Consistently Profitable Japanese Nano Cap at 0.3x P/TBV
9776.T Sapporo Clinical Laboratory: Cheap at 0.3x TBV, 7x PE. Operates retail pharmacies & clinical labs in Hokkaido. 7% 10yr BV growth, slow but profitable (only 2 loss years since '97 IPO). Doubled dividend to 2.2% yield. Chairman owns 39%. Spent ¥5.7B on lavish new HQ vs ¥3.5B market cap. Talks of 8% ROE goal (3x EPS) & M&A growth, but poor capital allocation. Nano-cap w/ no coverage, violated 400 holder rule. Net cash but most assets in RE.
Read full article (5 min)